HF modifying therapies, such as beta blockers and renin–angiotensin–aldosterone system inhibitors, were more commonly used in both groups, whereas digoxin, higher doses of loop diuretics and CRT were more prevalent among deceased. The gene discussed is REN; the disease is hydrops fetalis.